MATTHEW BERILLA, PA
Physician Assistant in COACHELLA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MATTHEW BERILLA, PA filed 1,059 Medicare Part D claims in 2023 as a Physician Assistant in COACHELLA, California, prescribing 83% generic.
- 1K
- Part D claims, 2023
- 83%
- generic prescribing
- $61.04
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MATTHEW BERILLA, PA's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
1,059 Top 24% higher than 76% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about MATTHEW BERILLA, PA?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Physician Assistant compares to other specialties among California providers
Physician Assistant share within California
Physician Assistant is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Physician Assistant (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Physician Assistant ABMS/AOA estimate
Est. board-certified rate (Physician Assistant) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Physician Assistant US NPIs
Specialty board-certified rate — Physician Assistant estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MATTHEW BERILLA, PA appears in the CMS NPPES registry as a Physician Assistant provider holding PA credentials at 50249 CESAR CHAVEZ ST STE K, COACHELLA, CA, 92236, with a listed phone of (760) 393-0555. NPI 1457865677 was issued on 11/27/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BERILLA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,059 prescription claims written by this provider, covering 334 Medicare beneficiaries and totaling roughly $122K in drug spend, split 17% brand-name and 83% generic by claim count, with an opioid prescribing rate of 1.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Physician Assistant is a high-volume specialty nationwide, with 149,975 enrolled providers across 56 states and an average of 790 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1457865677 |
|---|---|
| Specialty | Physician Assistant |
| Credentials | PA |
| Gender | Male |
| NPI Issued | 11/27/2017 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MATTHEW BERILLA, PA's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MATTHEW BERILLA, PA. Source: openpaymentsdata.cms.gov.
Total received
$61
Largest payer
Xeris Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MATTHEW BERILLA, PA. To verify MATTHEW BERILLA, PA's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
17% brand-name claims vs 83% generic, on 1,059 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,714
- Total Day Supply
- 47,361
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $102K
- Generic Drug Cost
- $20K
- Opioid Claims
- 16 (1.5% rate)
- Antibiotic Claims
- 68
Patient Demographics
- Average Patient Age
- 70.2 years
- Avg HCC Risk Score
- 1.33
- Gender Split
- 53% female / 47% male
- Age Distribution
- <65: 52, 65-74: 185, 75-84: 71, 85+: 26
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MATTHEW BERILLA, PA prescribes most
Top Medicare Part D drugs by claim count, 2023
- Metformin Hcl
Metformin Hcl
71 claims
- Lisinopril
Lisinopril
63 claims
- Atorvastatin Calcium
Atorvastatin Calcium
50 claims
- Levothyroxine Sodium
Levothyroxine Sodium
45 claims
- Amlodipine Besylate
Amlodipine Besylate
36 claims
- Meloxicam
Meloxicam
33 claims
- Omeprazole
Omeprazole
30 claims
- Rosuvastatin Calcium 28
Rosuvastatin Calcium
28 claims
| Drug | Claims |
|---|---|
| Metformin Hcl | 71 |
| Lisinopril | 63 |
| Atorvastatin Calcium | 50 |
| Levothyroxine Sodium | 45 |
| Amlodipine Besylate | 36 |
| Meloxicam | 33 |
| Omeprazole | 30 |
| Rosuvastatin Calcium | 28 |
| Cephalexin | 22 |
| Losartan Potassium | 22 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Physician Assistant Overview
How MATTHEW BERILLA, PA fits within the Physician Assistant landscape nationally.
MATTHEW BERILLA, PA's 1,059 claims are above the specialty average of 790.
Nearby Physician Assistant Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BERILLA.
Compare Physician Assistant nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is MATTHEW BERILLA, PA's specialty? ▼
How much does MATTHEW BERILLA, PA prescribe under Medicare Part D? ▼
Where is MATTHEW BERILLA, PA located? ▼
What is MATTHEW BERILLA, PA's NPI number? ▼
Does MATTHEW BERILLA, PA prescribe more brand-name or generic drugs? ▼
Does MATTHEW BERILLA, PA prescribe opioids? ▼
How many Physician Assistant providers are there in the US? ▼
What drugs does MATTHEW BERILLA, PA prescribe most often? ▼
Does MATTHEW BERILLA, PA accept Medicare? ▼
How can I verify MATTHEW BERILLA, PA's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology